Notably, a decrease in cell proliferation was observed in cells treated with the combination of oligomycin and palbociclib compared to palbociclib alone (Figure 2f), indicating that inhibition of mitochondrial metabolism can increase the sensitivity of BRAF mutant melanoma cells to palbociclib. This evidence concerns the gene BRAF and melanoma.